Michael Chiorean
- Gastroenterology top 1%
- Gastrointestinal Bleeding Diagnosis and Treatment 15
- Hepatology top 5%
- Liver Diseases and Immunity 10
- Genetics top 2%
- Inflammatory Bowel Disease 45
- Equine top 5%
- Surgery top 5%
- Gastrointestinal disorders and treatments 12
- Esophageal and GI Pathology 10
- Eosinophilic Esophagitis 9
-
- Microscopic Colitis 23
-
- Colorectal Cancer Screening and Detection 10
- Co-authors
- Kumaresan SandrasegaranSéverine VermeireCynthia S. JohnsonLaurent Peyrin‐BirouletJulián PanésWilliam J. SandbornDean D. T. MaglinteJohn C. Lappas
- Cited by
- GastroenterologyHepatologyGenetics
- Journals
- Gastroenterology (17 papers)Journal of Crohn s and Colitis (14 papers)Gastrointestinal Endoscopy (12 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Michael Chiorean
87 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Gastroenterology 384
- Hepatology 227
- Genetics 747
- Equine 40
- Surgery 850
Countries citing papers authored by Michael Chiorean
This map shows the geographic impact of Michael Chiorean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chiorean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chiorean more than expected).
Fields of papers citing papers by Michael Chiorean
This network shows the impact of papers produced by Michael Chiorean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chiorean. The network helps show where Michael Chiorean may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Chiorean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 26 | |
| 8 | Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studiesbreakdown → | 2023 | 190 |
| 9 | 2023 | 3 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 8 | |
| 13 | 2019 | 22 | |
| 14 | 2018 | 1 | |
| 15 | 2015 | 1 | |
| 16 | 2015 | 15 | |
| 17 | PROLIFERATION AND APOPTOSIS BIOMARKER MODULATION IN A PHASE II COLORECTAL (CRC) CHEMOPREVENTION TRIAL OF ATORVASTATIN, SULINDAC, OR OLIGOFRUCTOSE-ENRICHED INLULIN: A CANCER PREVENTION NETWORK (CPN) TRIAL | 2010 | 2 |
| 18 | 2010 | 68 | |
| 19 | 2009 | 17 | |
| 20 | 1996 | 108 |
About Michael Chiorean
Michael Chiorean is a scholar working on Gastroenterology, Hepatology and Genetics, having authored 94 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (45 papers), Microscopic Colitis (23 papers), Gastrointestinal Bleeding Diagnosis and Treatment (15 papers), Gastrointestinal disorders and treatments (12 papers), Colorectal Cancer Screening and Detection (10 papers), Liver Diseases and Immunity (10 papers), Esophageal and GI Pathology (10 papers) and Eosinophilic Esophagitis (9 papers). The work is most often cited by research in Gastroenterology (384 citations), Hepatology (227 citations) and Genetics (747 citations). Michael Chiorean has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Kumaresan Sandrasegaran, Séverine Vermeire, Cynthia S. Johnson, Laurent Peyrin‐Biroulet, Julián Panés, William J. Sandborn, Dean D. T. Maglinte, John C. Lappas, Rajiv Saxena and Attila Nakeeb. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, Gastrointestinal Endoscopy, The American Journal of Gastroenterology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.